Artificial Intelligence for Optimizing Cancer Imaging: User Experience Study
JMIR Cancer · 2024
DOI: 10.2196/52639 ↗At a glance
Journal article in JMIR Cancer, 2024. Written by Iman Hesso and 9 co-authors. Institution: Pharmacy Department, Faculty of Health, Science, Social Care and Education, Kingston University London, Kingston Upon Thames, United Kingdom. Major MEDLINE topics: Artificial Intelligence, Neoplasms. Cited 3 times so far (Crossref); 28 references. The full text is freely available in PubMed Central.
Abstract (original language)
Background
The need for increased clinical efficacy and efficiency has been the main force in developing artificial intelligence (AI) tools in medical imaging. The INCISIVE project is a European Union–funded initiative aiming to revolutionize cancer imaging methods using AI technology. It seeks to address limitations in imaging techniques by developing an AI-based toolbox that improves accuracy, specificity, sensitivity, interpretability, and cost-effectiveness.
Objective
To ensure the successful implementation of the INCISIVE AI service, a study was conducted to understand the needs, challenges, and expectations of health care professionals (HCPs) regarding the proposed toolbox and any potential implementation barriers.
Methods
A mixed methods study consisting of 2 phases was conducted. Phase 1 involved user experience (UX) design workshops with users of the INCISIVE AI toolbox. Phase 2 involved a Delphi study conducted through a series of sequential questionnaires. To recruit, a purposive sampling strategy based on the project’s consortium network was used. In total, 16 HCPs from Serbia, Italy, Greece, Cyprus, Spain, and the United Kingdom participated in the UX design workshops and 12 completed the Delphi study. Descriptive statistics were performed using SPSS (IBM Corp), enabling the calculation of mean rank scores of the Delphi study’s lists. The qualitative data collected via the UX design workshops was analyzed using NVivo (version 12; Lumivero) software.
Results
The workshops facilitated brainstorming and identification of the INCISIVE AI toolbox’s desired features and implementation barriers. Subsequently, the Delphi study was instrumental in ranking these features, showing a strong consensus among HCPs (W=0.741, P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Pharmacy Department, Faculty of Health, Science, Social Care and Education, Kingston University London, Kingston Upon Thames, United Kingdom.
- Department of Nursing, Cyprus University of Technology, Limassol, Cyprus.
- Department of Nursing, International Hellenic University, Thessaloniki, Greece.
- Urology Department, Hospital Clinic de Barcelona, Barcelona, Spain.
- Department of Advanced Biomedical Science, University of Naples Federico II, Naples, Italy.
- Department of Radiology, Faculty of Medicine, University of Novi Sad, Novi Sad, .
ORCID profiles: Iman Hesso, Lithin Zacharias, Reem Kayyali, Andreas Charalambous, Maria Lavdaniti, Evangelia Stalika, Tarek Ajami, Wanda Acampa, Jasmina Boban, Shereen Nabhani-Gebara
Cite
APA
Hesso, I., Zacharias, L., Kayyali, R., Charalambous, A., Lavdaniti, M., Stalika, E., Ajami, T., Acampa, W., Boban, J., & Nabhani-Gebara, S. (2024). Artificial Intelligence for Optimizing Cancer Imaging: User Experience Study. JMIR Cancer. https://doi.org/10.2196/52639
Vancouver
Hesso I, Zacharias L, Kayyali R, Charalambous A, Lavdaniti M, Stalika E, et al. Artificial Intelligence for Optimizing Cancer Imaging: User Experience Study. JMIR Cancer. 2024. doi:10.2196/52639
BibTeX
@article{Hesso2024,
author = {Hesso, Iman and Zacharias, Lithin and Kayyali, Reem and Charalambous, Andreas and Lavdaniti, Maria and Stalika, Evangelia and Ajami, Tarek and Acampa, Wanda and Boban, Jasmina and Nabhani-Gebara, Shereen},
title = {Artificial Intelligence for Optimizing Cancer Imaging: User Experience Study},
journal = {JMIR Cancer},
year = {2024},
doi = {10.2196/52639}
}
EUVIMED